MANAGEMENT & ADVISORS

Officers & Directors

KIPTON LADE

BS Biomedical Engineering, MS Electrical Engineering, MBA

President & CEO / Director

Mr. Lade has over 25 years of experience developing, executing strategic plans and launching new medical technologies and therapies on a global level. Most recently, Mr. Lade served as General Manager for Alvimedica in Toronto, Canada. At Alvimedica, he drove all aspects of this North American business start-up including: Finance, Strategic Planning, Marketing, Sales, Business Development, Clinical and Regulatory. Prior to joining Alvimedica, Mr. Lade served as the Director of Sales and marketing at Boston Scientific from 2008 to 2014. From 2006 to 2008, Mr. Lade served as Managing Director for BIOTRONIK in Canada, where he established direct selling organization transitioning from a local distributor, drove revenue growth, and built strong teams in Marketing, Quality, Human Resources, Sales, Finance and Clinical Studies. From 1998 to 2006, Mr. Lade served in positions of increasing responsibility at St. Jude Medical in Toronto Canada and Sylmar, CA. As General Manager of St. Jude Medical Canada he drove revenue growth, and collaborated with key opinion leaders to launch two major clinical studies. As Senior Director Global Product Marketing, his teams drove dramatic increases in global revenue share, with the launch of high energy ICDs, innovative lead systems and new pacemaker platforms. As Director of Emerging Indications he led a team that designed and implemented clinical studies that resulted in new indications for Atrial Fibrillation patients receiving pacemakers.

Mr. Lade received his MBA from the University of St. Thomas, St. Paul, MN, earned an MS in Electrical Engineering from Marquette University, Milwaukee, WI, and a BS in Biomedical Engineering from Marquette University, Milwaukee, WI. Mr. Lade holds a US patent for an Implantable Syncope Monitor. He served as the President of a local school board, volunteered for the FIFA world cup and is a Dual Citizen of the USA and Canada.

JOSEPH A. FISHER

MD, FRCP(C)

Chief Scientist / Director

Dr. Fisher is a co-founder of Thornhill Medical and Professor in the faculty of Medicine at the University of Toronto. He is currently a Staff Anaesthetist at the University Health Network and Senior Scientist, Human Physiology & Clinical Investigation, at Toronto General Research Institute. He has published over 120 papers in peer-reviewed journals, and designed and consulted on products for NASA, Government of Canada, United States Marine Corps, and various companies. He is an inventor on over 25 issued and pending patents, including the core technology behind Thornhill’s technologies. Click here to search Pubmed for Dr. Fisher’s research or here for Dr. Fisher’s iamscientist.com page.

LUDWIK FEDORKO

MD, PhD, FRCP(C)

Senior Scientist / Director

Dr. Fedorko holds a specialty certificate in Anesthesiology from The Royal College of Physicians (Canada). After working as Staff Scientist at the Hospital for Sick Children Research Institute (Toronto) and The Samuel Lunenfeld Research Institute of Mt. Sinai Hospital (Toronto) he joined the Department of Anesthesia at The Toronto General Hospital. His clinical practice expertise is in the area of cardiovascular anesthesiology, heart and lung transplantation and cardiovascular intensive care. Dr. Fedorko is the author of numerous publications.

STEVE ISCOE

PhD

Director

Steve Iscoe, a collaborator of Dr Fisher since 1994, was a founding shareholder and president of one of the companies that became Thornhill Scientific. A retired Professor of Physiology at Queen’s University, his research focused primarily on control of the diaphragm, particularly how respiratory loads induce cardiorespiratory failure. An associated aspect was the development of a novel blood test for detecting skeletal muscle injury. His background as a respiratory physiologist contributed to the development of the company’s breathing circuits that maintain carbon dioxide levels independent of ventilation, and to their research and clinical applications.

Management Team

LESLEY GOULDIE

B.Com., B.Acc., CPA, CA

Chief Business Officer

Seasoned financial professional, with over 20 years of senior leadership experience in both startups and Fortune 500 companies
Track record of providing financial acumen to organizations involved in microelectronics, biotechnology and content creation, to meet and exceed financial objectives
Accomplished in monetizing assets, creating new business models and facilitating the success of the team

VESO TIJANIC

B.Sc, M.Sc.

Chief Operating Officer

Progressive engineering positions with 25 years of the new product and 15 in medical product development
Number of patents across diverse product lines
Specialized in mechanical design and fabrication

Advisory Board

David Mikulis, MD, FRCR

Dr. Mikulis is Full Professor and Co-Director of Medical Imaging Research in the Dept. of Medical Imaging at the University of Toronto and the University Health Network. He is also Director of the Radiology Residency Research Program, and Director of the Functional Imaging Research Lab. Dr. Mikulis is one of the founding members of the American Society of Functional Neuroradiology (ASFNR), and currently serves on the ASFNR Executive Committee.

Seemant Chaturvedi, MD, FAHA, FAAN

Dr. Chaturvedi is Professor of Neurology at Wayne State University School of Medicine and Director of the Wayne State/Detroit Medical Center Comprehensive Stroke Program. He has co-edited the books Transient Ischemic Attacks in 2004 and Carotid Artery Stenosis: Current and Emerging Treatments in 2005. He was chairman of the American Academy of Neurology carotid endarterectomy guidelines committee, with the guidelines published in 2005. He is currently on the steering committee of several stroke prevention studies.

Colin Derdeyn, MD

Dr. Derdeyn is professor of Radiology, Neurology and Neurological Surgery at Washington University and Director of the Washington University/Barnes Jewish Hospital Stroke and Cerebrovascular Center. He is a Principal Investigator for the SAMMPRIS trial, an ongoing randomized trial of angioplasty and stenting for intracranial atherosclerotic disease. He directs the Washington University SPOTRIAS (Specialized Program for Translational Research in Acute Stroke) Center. Dr. Derdeyn also chairs the Data and Safety Monitoring Boards for two ongoing NIH funded acute stroke clinical trials (MR Rescue and ICTus 2/3).

Brendan Cunneen, CMC

A Certified Management Consultant, Brendan Cunneen is a senior business executive who has been directly involved in the development and delivery of financing and consulting programs to address the needs of Canadian entrepreneurs for over 30 years. He retired from Business Development Bank of Canada as Vice President of Consulting Services in 2009.
As part owner, Mr Cunneen then undertook the role of COO of a consulting practice, which after experiencing significant growth, was acquired by Ernst & Young LLP in 2011. Subsequently acting as Special Adviser to the Canadian Tax Practice of Ernst & Young, he was responsible for the implementation of a major growth initiative across Canada in the same practice area, including a further acquisition in 2013.
Mr Cunneen is currently active in mergers and acquisition work, and has created a Pan Canadian roster of associates filtering potential transactions and funnelling these opportunities to the correct source of capital to maximize the value of the company for its shareholders.